𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aclarubicin and Low-Dose Cytosine Arabinoside in Combination with Granulocyte Colony-Stimulating Factor in Treating Acute Myeloid Leukemia Patients with Relapsed or Refractory Disease and Myelodysplastic Syndrome: A Multicenter Study of 112 Chinese Patients

✍ Scribed by J. M. Li; Y. Shen; D. P. Wu; H. Liang; J. Jin; F. Y. Chen; Y. P. Song; J. M. Wang; X. F. Qiu; M. Hou; Z. C. Qiu; Z. X. Shen

Book ID
111835764
Publisher
Carden Jennings Publishing
Year
2005
Tongue
English
Weight
114 KB
Volume
82
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy with low-dose c
Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient